Home » Biotechnology » Hospital Acquired Disease Testing Market

Hospital Acquired Disease Testing Market By Product (Instrument ,Reagents and Consumables)By Test Type (Molecular Diagnostics, Immunoassay ,Others) Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 7229 | Report Format : PDF

Key Highlights of the Report

How are the major segments performing in the Hospital Acquired Disease Testing market?

  • In 2022, the consumables and reagents segment dominated the market. Low awareness and a high prevalence of hospital acquired illnesses in low- and middle-income nations are blamed for the segment’s growth.
  • In 2022, the market was dominated by the immunoassay category. The increase in cancer cases, infectious disorders, and sudden pandemic outbreaks all contribute to the segment’s growth.
  • In 2022, the drug-resistance testing market had the highest market share.
  • Due to the high prevalence of pneumonia in hospitalized patients, the urinary tract segment dominated the market in 2022.

What is the Market Size of Hospital Acquired Disease Testing regarding Value?

The global hospital acquired disease testing market is anticipated to grow at a substantial CAGR of 17.9% in the upcoming years. The global Fermentation Chemicals industry was estimated to be worth USD 9.9 billion in 2022 and was expected to be worth USD 31.3 billion by 2030.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Which region dominated the Hospital Acquired Disease Testing market?

North America held the highest portion of the global market for hospital acquired infections. The expanding emphasis on healthy lifestyles and disease prevention among consumers distinguishes market growth in this region. It is shown in the rising demand for sterilization and disinfection products and services. The increase in the number of older adults in the region and the rise of chronic diseases, the requirement for hospital-acquired disease testing to reduce the prevalence of HAIs, the adoption of supportive government initiatives and the strict implementation of sterilization and disinfection regulations are all factors driving the market for hospital acquired infections in the region.

Which are the key countries in the hospital acquired disease testing market?

The market for hospital acquired disease testing in the US is driven by an aging population, demand for HAI diagnostics from middle- and low-income countries, and the development of technologically advanced diagnostic instruments. Furthermore, it is advantageous to build technologically advanced diagnostic tools that quickly deliver precise and reliable results.

The market for hospital acquired disease diagnostics in China is expanding due to rising government initiatives and growing awareness among medical professionals. Furthermore, China has poor standards of cleanliness and hygiene.

How is the economy impacting global hospital acquired disease testing growth?

The increase in inflation rates impacts the market many countries have seen. Additionally, market liquidity may decline. Businesses that imported goods from Russia and Ukraine suffered huge losses due to the Russia-Ukraine War. All these elements have the potential to constrain market growth. The Covid-19 commercial release impacted capital expenditures at significant companies. The hospital-acquired illness testing market’s raw material supply chain has been considerably influenced by the government-imposed lockout and restrictions on cross-border movement, leading to higher prices and, subsequently, higher raw material costs for manufacturers.

What is the competitive environment of the hospital acquired disease testing market?

The market for hospital acquired disease testing market is fragmented. There is a presence of various regional and multinational players in the market who are focused towards market expansion through different strategies. For instance,  The CEERAM (European Centre for Expertise and Research on Microbial Agents), a cutting-edge molecular virology facility with a focus on the detection of foodborne and environmental viruses, was acquired by bioMérieux in January 2015.

Executive Summary

What are the key trends in the Hospital Acquired Disease Testing market?

  • The market for hospital-acquired illness testing is anticipated to develop as diseases such as central line-associated bloodstream infection (CLABSI), catheter-related bloodstream infection (CRBSI), and others rise.
  • The incidence of nosocomial infections, overall medical costs, hospital stays, and mortality are controlled through quick and effective infection detection methods.

What is the market understanding of the Hospital Acquired Disease Testing Market?

Nosocomial infection, or hospital acquired disease, is a localized or systemic ailment in patients that develops due to an adverse reaction to infectious toxin agents while receiving medical care and is not present at admission. Longer hospital stays, antibiotic resistance, permanent impairments, and a higher mortality rate are all consequences of hospital acquired infections. Viral, fungal, and bacterial pathogens are all involved in hospital-acquired illnesses.

Infections at surgical sites, pneumonia linked to ventilators, and urinary tract infections linked to catheters are among the illnesses contracted in hospitals. Microarray, PCR, and solid phase hybridization are techniques used for disease testing, diagnosis, and prevention associated with hospital acquired conditions. Due to the proximity of the urethra to the anus, which increases the risk of bacterial invasion from the large intestine into the urinary system, urinary tract infections are most frequent in patients who use urinary catheters.

What are the key investments by the hospital acquired disease testing market players?

Manufacturers are creating sophisticated testing kits to improve the effectiveness of diagnosing diseases contracted in hospitals. For instance, the Methicillin-resistant Staphylococcus aureus (MRSA) bacterium was detected using the cobas vivoDx MRSA diagnostic test, which was approved by the US Food and Drug Administration (FDA) in December 2019 for F.Hoffmann-La Roche Ltd. Cobas vivoDx MRSA’s certification is meant to help manage and prevent Methicillin-resistant Staphylococcus aureus (MRSA) infections in healthcare facilities.

Some major players in the hospital acquired disease testing market are Abbott Laboratories, Ecolab, Johnson & Johnson, Merck Kgaa, Bayer Schering Pharma Llc, Becton Dickinson And Company, Pfizer Inc., Steris Plc, Hologic, Inc., Danaher Corporation.

What are the Major Driving Factors for the Hospital Acquired Disease Testing Market?

The prevalence of pathogens, bacterial, fungal, and viral diseases, as well as rising morbidity rates owing to infections around the world, are some of the key factors influencing the hospital acquired disease testing market. Another significant factor is the lengthening of hospital stays, mostly brought on by hospital acquired infections. HAI is most prone to happen in the intensive care units (ICU) and emergency rooms (ER). According to the US CDC, 5% of hospitalized patients contract an HAI within 72 hours of admission. Incubating infections that are not clinically evident at admission are not included. Bacterial nosocomial infections are the most common type of illness that spreads in healthcare facilities. These illnesses are frequently spread when hospital employees do not maintain basic cleanliness and become complacent.

What are the Major Risks for the Hospital Acquired Disease Testing Market?

Reprocessing used medical equipment allows healthcare providers to cut costs and waste. Medical instruments that can be reused include stethoscopes, endoscopes, and surgical forceps. However, there are issues with the effectiveness and safety of recycled devices. After improper cleaning and sterilization, blood, tissue, and other biological waste can remain on instruments. By allowing bacteria to endure the subsequent sterilization or disinfection procedure, the debris may enable HAIs to develop. Other negative patient effects from insufficient reprocessing include tissue irritation from leftover reprocessing components such as chemical disinfectants. These concerns restrict hospital staff members’ adoption of reprocessing.

Which is the key end user in the hospital acquired disease testing market?

The hospital market segment is anticipated to see the greatest CAGR over the forecast period. The rising prevalence of HAIs, rising use of single-use medical devices, expanding medical device sector, and rising number of surgical procedures globally are all important contributors to the market’s highest CAGR. The growth of the hospital segment is also fueled by rising demand for minimally invasive surgeries and expansion in the creation of outpatient services. Additionally, the number of outpatients has expanded dramatically due to growing public awareness of health issues and government measures to provide hospital healthcare services.

How is the hospital acquired disease testing market performing in regions?

North America held the largest share of the global market for hospital acquired infections. What separates market growth in this region is the growing emphasis on healthy lifestyles and disease prevention among consumers, which is shown in the increased demand for and adoption of sterilization and disinfection products and services. The market for hospital-acquired infections in the region is being driven by several factors, including an increase in the number of older adults in the region over the coming years and the consequent rise in the prevalence of chronic diseases, the need for hospital-acquired disease testing to reduce the prevalence of HAIs, the adoption of supportive government initiatives, and the strict implementation of sterilization and disinfection regulations.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the hospital acquired disease testing market?

Major players are concentrating on the creation of effective testing technology. Global demand for these goods has increased due to the widespread availability of more advanced infection detection technologies, particularly those under molecular diagnostics, and their demonstrated effectiveness in giving faster findings.

REPORT ATTRIBUTE DETAILS
Hospital Acquired Disease Testing Market by Volume Yes
Hospital Acquired Disease Testing Market by Value Yes
Hospital Acquired Disease Testing Market, Tornado Analysis Yes
Hospital Acquired Disease Testing Market, STAR Analysis Yes
Hospital Acquired Disease Testing Market, SRC Analysis Yes
Hospital Acquired Disease Testing Market, Import-Export Data Yes (On Demand)
Hospital Acquired Disease Testing Market Pricing Analysis Yes (On Demand)
Hospital Acquired Disease Testing Market Segment Analysis By Product (Instrument, Reagents and Consumables)

By Test Type (Molecular Diagnostics, Immunoassay and Others)

By Application (Disease Testing and Drug-Resistance Testing)

By Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI) and Others)

By End User (Hospital, Standalone Laboratories and Others)

Hospital Acquired Disease Testing Market, Regional Analysis North America (US, Canada, Mexico)

Europe (Germany, UK, Spain, France, Italy, and Rest of Europe)

Asia Pacific (China, Japan, India, South Korea, South East Asia, and Rest of Asia Pacific)

Latin America (Brazil, Argentina, and Rest of Latin America)

Middle East and Africa (South Africa, GCC Countries, and Rest of Middle East and Africa)

Hospital Acquired Disease Testing Market Key Companies Abbott Laboratories, Ecolab, Johnson & Johnson, Merck Kgaa, Bayer Schering Pharma Llc, Becton Dickinson And Company, Pfizer Inc., Steris Plc, Hologic, Inc., and Danaher Corporation
Hospital Acquired Disease Testing Market Competitive Landscape Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted

Segmentation of Global Hospital Acquired Disease Testing Market-

Global Hospital Acquired Disease Testing Market – By Product

  • Instrument
  • Reagents and Consumables

Global Hospital Acquired Disease Testing Market – By Test Type

  • Molecular Diagnostics
  • Immunoassay
  • Others

Global Hospital Acquired Disease Testing Market – By Application

  • Disease Testing
  • Drug-Resistance Testing

Global Hospital Acquired Disease Testing Market – By Infection Type

  • Hospital Acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infections (UTI)
  • Others

Global Hospital Acquired Disease Testing Market – By End User

  • Hospital
  • Standalone Laboratories
  • Others

Global Hospital Acquired Disease Testing Market – By Region

  • North America
    • The US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • The UK.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Hospital Acquired Disease Testing Market
2.2. Global Hospital Acquired Disease Testing Market, By Product
2.3. Global Hospital Acquired Disease Testing Market, By Test Type
2.4. Global Hospital Acquired Disease Testing Market, By Application
2.5. Global Hospital Acquired Disease Testing Market, By Infection Type
2.6. Global Hospital Acquired Disease Testing Market, By End User
2.7. Global Hospital Acquired Disease Testing Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Hospital Acquired Disease Testing Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Test Type
3.5.2. Product
3.5.3. Application
3.5.4. Infection Type
3.5.5. End User
3.5.6. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Hospital Acquired Disease Testing Market, By Infection Type
7.1. Global Hospital Acquired Disease Testing Market Overview, By Infection Type
7.1.1. Global Hospital Acquired Disease Testing Market Revenue Share, By Infection Type, 2022 Vs 2030 (in %)
7.2. Hospital Acquired Pneumonia
7.2.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
7.3. Bloodstream Infections
7.3.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
7.4. Surgical Site Infections
7.4.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
7.5. GASTROINTESTINAL INFECTIONS
7.5.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
7.6. Urinary Tract Infections (UTI)
7.6.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
7.7. Others
7.7.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)

8. Global Hospital Acquired Disease Testing Market, by Application, 2017-2030 (US$ Mn)
8.1. Global Hospital Acquired Disease Testing Market Overview, by Application
8.1.1. Global Hospital Acquired Disease Testing Market, By Application, 2022 vs 2030 (in%)
8.2. Disease Testing
8.2.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
8.3. Drug-Resistance Testing
8.3.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)

9. Global Hospital Acquired Disease Testing Market, by Test Type, 2017-2030 (US$ Mn)
9.1. Global Hospital Acquired Disease Testing Market Overview, by Test Type
9.1.1. Global Hospital Acquired Disease Testing Market, By Application, 2022 vs 2030 (in%)
9.2. Molecular Diagnostics
9.2.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
9.3. Immunoassay
9.3.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
9.4. Others
9.4.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)

10. Global Hospital Acquired Disease Testing Market, by Product, 2017-2030 (US$ Mn)
10.1. Global Hospital Acquired Disease Testing Market Overview, by Product
10.1.1. Global Hospital Acquired Disease Testing Market, By Application, 2022 vs 2030 (in%)
10.2. Instrument
10.2.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
10.3. Reagents and Consumables
10.3.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)

11. Global Hospital Acquired Disease Testing Market, by End User, 2017-2030 (US$ Mn)
11.1. Global Hospital Acquired Disease Testing Market Overview, by End User
11.1.1. Global Hospital Acquired Disease Testing Market, By Application, 2022 vs 2030 (in%)
11.2. Standalone Laboratories
11.2.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
11.3. Hospitals
11.3.1. Global Hospital Acquired Disease Testing Market, By Region, 2017-2030 (US$ Mn)
11.4. Others
11.4.1. Global Dr ug Of Abuse Testing Market, By Region, 2017-2030 (US$ Mn)

12. Global Hospital Acquired Disease Testing Market, By Region
12.1. Global Hospital Acquired Disease Testing Market Overview, by Region
12.1.1. Global Hospital Acquired Disease Testing Market, By Region, 2022 vs 2030 (in%)
12.2. Infection Type
12.2.1. Global Hospital Acquired Disease Testing Market, By Infection Type, 2017-2030 (US$ Mn)
12.3. Test Type
12.3.1. Global Hospital Acquired Disease Testing Market, By Test Type, 2017-2030 (US$ Mn)
12.4. Product
12.4.1. Global Hospital Acquired Disease Testing Market, By Product, 2017-2030 (US$ Mn)
12.5. End User
12.5.1. Global Hospital Acquired Disease Testing Market, By End User, 2017-2030 (US$ Mn)
12.6. Application
12.6.1. Global Hospital Acquired Disease Testing Market, By Application, 2017-2030 (US$ Mn)

13. North America Hospital Acquired Disease Testing Market Analysis
13.1. North America Hospital Acquired Disease Testing Market, By Infection Type, 2017-2030(US$ Mn)
13.1.1. Overview
13.1.2. SRC Analysis
13.2. North America Hospital Acquired Disease Testing Market, by Application, 2017-2030(US$ Mn)
13.2.1. Overview
13.2.2. SRC Analysis
13.3. North America Hospital Acquired Disease Testing Market, by Test Type, 2017-2030(US$ Mn)
13.3.1. Overview
13.3.2. SRC Analysis
13.4. North America Hospital Acquired Disease Testing Market, by Product, 2017-2030(US$ Mn)
13.4.1. Overview
13.4.2. SRC Analysis
13.5. North America Hospital Acquired Disease Testing Market, by End User, 2017-2030(US$ Mn)
13.5.1. Overview
13.5.2. SRC Analysis
13.6. North America Hospital Acquired Disease Testing Market, by Country, 2017-2030 (US$ Mn)
13.6.1. North America Hospital Acquired Disease Testing Market, by Country, 2022 Vs 2030 (in%)
13.6.2. U.S.
13.6.2.1. U.S. Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
13.6.2.2. U.S. Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
13.6.2.3. U.S. Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
13.6.2.4. U.S. Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
13.6.2.5. U.S. Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
13.6.2.6. U.S. Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
13.6.3. Canada
13.6.3.1. Canada Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
13.6.3.2. Canada Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
13.6.3.3. Canada Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
13.6.3.4. Canada Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
13.6.3.5. Canada Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
13.6.3.6. Canada Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
13.6.4. Mexico
13.6.4.1. Mexico Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
13.6.4.2. Mexico Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
13.6.4.3. Mexico Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
13.6.4.4. Mexico Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
13.6.4.5. Mexico Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
13.6.4.6. Mexico Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)

14. Europe Hospital Acquired Disease Testing Market Analysis
14.1. Europe Hospital Acquired Disease Testing Market, By Infection Type, 2017-2030(US$ Mn)
14.1.1. Overview
14.1.2. SRC Analysis
14.2. Europe Hospital Acquired Disease Testing Market, by Application, 2017-2030(US$ Mn)
14.2.1. Overview
14.2.2. SRC Analysis
14.3. Europe Hospital Acquired Disease Testing Market, by Test Type, 2017-2030(US$ Mn)
14.3.1. Overview
14.3.2. SRC Analysis
14.4. Europe Hospital Acquired Disease Testing Market, by Product, 2017-2030(US$ Mn)
14.4.1. Overview
14.4.2. SRC Analysis
14.5. Europe Hospital Acquired Disease Testing Market, by End User, 2017-2030(US$ Mn)
14.5.1. Overview
14.5.2. SRC Analysis
14.6. Europe Hospital Acquired Disease Testing Market, by Country, 2017-2030 (US$ Mn)
14.6.1. Europe Hospital Acquired Disease Testing Market, by Country, 2022 Vs 2030 (in%)
14.6.2. Germany
14.6.2.1. Germany Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
14.6.2.2. Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
14.6.2.3. Germany Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
14.6.2.4. Germany Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
14.6.2.5. Germany Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
14.6.2.6. Germany Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
14.6.3. France
14.6.3.1. France Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
14.6.3.2. France Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
14.6.3.3. France Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
14.6.3.4. France Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
14.6.3.5. France Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
14.6.3.6. France Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
14.6.4. UK
14.6.4.1. UK Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
14.6.4.2. UK Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
14.6.4.3. UK Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
14.6.4.4. UK Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
14.6.4.5. UK Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
14.6.4.6. UK Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
14.6.5. Italy
14.6.5.1. Italy Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
14.6.5.2. Italy Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
14.6.5.3. Italy Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
14.6.5.4. Italy Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
14.6.5.5. Italy Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
14.6.5.6. Italy Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
14.6.6. Spain
14.6.6.1. Spain Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
14.6.6.2. Spain Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
14.6.6.3. Spain Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
14.6.6.4. Spain Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
14.6.6.5. Spain Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
14.6.6.6. Spain Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
14.6.7. Rest of Europe
14.6.7.1. Rest of Europe Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
14.6.7.2. Rest of Europe Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
14.6.7.3. Rest of Europe Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
14.6.7.4. Rest of Europe Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
14.6.7.5. Rest of Europe Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
14.6.7.6. Rest of Europe Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)

15. Asia Pacific Hospital Acquired Disease Testing Market Analysis
15.1. Asia Pacific Hospital Acquired Disease Testing Market, By Infection Type, 2017-2030(US$ Mn)
15.1.1. Overview
15.1.2. SRC Analysis
15.2. Asia Pacific Hospital Acquired Disease Testing Market, by Application, 2017-2030(US$ Mn)
15.2.1. Overview
15.2.2. SRC Analysis
15.3. Asia Pacific Hospital Acquired Disease Testing Market, by Test Type, 2017-2030(US$ Mn)
15.3.1. Overview
15.3.2. SRC Analysis
15.4. Asia Pacific Hospital Acquired Disease Testing Market, by Product, 2017-2030(US$ Mn)
15.4.1. Overview
15.4.2. SRC Analysis
15.5. Asia Pacific Hospital Acquired Disease Testing Market, by End User, 2017-2030(US$ Mn)
15.5.1. Overview
15.5.2. SRC Analysis
15.6. Asia Pacific Hospital Acquired Disease Testing Market, by Country, 2017-2030 (US$ Mn)
15.6.1. Asia Pacific Hospital Acquired Disease Testing Market, by Country, 2022 Vs 2030 (in%)
15.6.2. China
15.6.2.1. China Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.6.2.2. China Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
15.6.2.3. China Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
15.6.2.4. China Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
15.6.2.5. China Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
15.6.2.6. China Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
15.6.3. Japan
15.6.3.1. Japan Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.6.3.2. Japan Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
15.6.3.3. Japan Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
15.6.3.4. Japan Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
15.6.3.5. Japan Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
15.6.3.6. Japan Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
15.6.4. India
15.6.4.1. India Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.6.4.2. India Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
15.6.4.3. India Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
15.6.4.4. India Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
15.6.4.5. India Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
15.6.4.6. India Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
15.6.5. South Korea
15.6.5.1. South Korea Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.6.5.2. South Korea Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
15.6.5.3. South Korea Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
15.6.5.4. South Korea Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
15.6.5.5. South Korea Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
15.6.5.6. South Korea Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
15.6.6. South-East Asia
15.6.6.1. South-East Asia Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.6.6.2. South-East Asia Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
15.6.6.3. South-East Asia Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
15.6.6.4. South-East Asia Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
15.6.6.5. South-East Asia Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
15.6.6.6. South-East Asia Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
15.6.7. Rest of Asia Pacific
15.6.7.1. Rest of Asia Pacific Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
15.6.7.2. Rest of Asia Pacific Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
15.6.7.3. Rest of Asia Pacific Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
15.6.7.4. Rest of Asia Pacific Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
15.6.7.5. Rest of Asia Pacific Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
15.6.7.6. Rest of Asia Pacific Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)

16. Latin America Hospital Acquired Disease Testing Market Analysis
16.1. Latin America Hospital Acquired Disease Testing Market, By Infection Type, 2017-2030(US$ Mn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. Latin America Hospital Acquired Disease Testing Market, by Application, 2017-2030(US$ Mn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. Latin America Hospital Acquired Disease Testing Market, by Test Type, 2017-2030(US$ Mn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. Latin America Hospital Acquired Disease Testing Market, by Product, 2017-2030(US$ Mn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. Latin America Hospital Acquired Disease Testing Market, by End User, 2017-2030(US$ Mn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. Latin America Hospital Acquired Disease Testing Market, by Country, 2017-2030 (US$ Mn)
16.6.1. Latin America Hospital Acquired Disease Testing Market, by Country, 2022 Vs 2030 (in%)
16.6.2. Brazil
16.6.2.1. Brazil Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
16.6.2.2. Brazil Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
16.6.2.3. Brazil Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
16.6.2.4. Brazil Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
16.6.2.5. Brazil Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
16.6.2.6. Brazil Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
16.6.3. Argentina
16.6.3.1. Argentina Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
16.6.3.2. Argentina Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
16.6.3.3. Argentina Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
16.6.3.4. Argentina Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
16.6.3.5. Argentina Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
16.6.3.6. Argentina Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
16.6.4. Rest of Latin America
16.6.4.1. Rest of Latin America Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
16.6.4.2. Rest of Latin America Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
16.6.4.3. Rest of Latin America Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
16.6.4.4. Rest of Latin America Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
16.6.4.5. Rest of Latin America Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
16.6.4.6. Rest of Latin America Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)

17. Middle East and Africa Hospital Acquired Disease Testing Market Analysis
17.1. Middle East and Africa Hospital Acquired Disease Testing Market, By Infection Type, 2017-2030(US$ Mn)
17.1.1. Overview
17.1.2. SRC Analysis
17.2. Middle East and Africa Hospital Acquired Disease Testing Market, by Application, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Middle East and Africa Hospital Acquired Disease Testing Market, by Test Type, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Middle East and Africa Hospital Acquired Disease Testing Market, by Product, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Middle East and Africa Hospital Acquired Disease Testing Market, by End User, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Middle East and Africa Hospital Acquired Disease Testing Market, by Country, 2017-2030 (US$ Mn)
17.6.1. Middle East and Africa Hospital Acquired Disease Testing Market, by Country, 2022 Vs 2030 (in%)
17.6.2. GCC Countries
17.6.2.1. GCC Countries Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
17.6.2.2. GCC Countries Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
17.6.2.3. GCC Countries Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
17.6.2.4. GCC Countries Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
17.6.2.5. GCC Countries Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
17.6.2.6. GCC Countries Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
17.6.3. South Africa
17.6.3.1. South Africa Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
17.6.3.2. South Africa Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
17.6.3.3. South Africa Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
17.6.3.4. South Africa Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
17.6.3.5. South Africa Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
17.6.3.6. South Africa Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)
17.6.4. Rest of Middle East and Africa
17.6.4.1. Rest of Middle East and Africa Hospital Acquired Disease Testing Market Estimates and Forecast, 2017-2030 (US$ Mn)
17.6.4.2. Rest of Middle East and Africa Hospital Acquired Disease Testing, By Infection Type, 2017-2030 (US$ Mn)
17.6.4.3. Rest of Middle East and Africa Hospital Acquired Disease Testing, By Application, 2017-2030 (US$ Mn)
17.6.4.4. Rest of Middle East and Africa Hospital Acquired Disease Testing, By Test Type, 2017-2030 (US$ Mn)
17.6.4.5. Rest of Middle East and Africa Hospital Acquired Disease Testing, By Product, 2017-2030 (US$ Mn)
17.6.4.6. Rest of Middle East and Africa Hospital Acquired Disease Testing, By End User, 2017-2030 (US$ Mn)

18. Company Profiles
18.1. Abbott Laboratories
18.1.1. Company Overview
18.1.2. Products/Services Portfolio
18.1.3. Geographical Presence
18.1.4. Financial Summary
18.1.4.1. Market Revenue and Net Profit (2019-2022)
18.1.4.2. Business Segment Revenue Analysis
18.1.4.3. Geographical Revenue Analysis
18.2. Ecolab
18.3. Johnson & Johnson
18.4. Merck Kgaa
18.5. Bayer Schering Pharma Llc
18.6. Becton Dickinson And Company
18.7. Pfizer Inc.
18.8. Steris Plc
18.9. Hologic, Inc.
18.10. Danaher Corporation

List of Figures
FIG. 1 Global Hospital Acquired Disease Testing Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Hospital Acquired Disease Testing Market Segmentation
FIG. 4 Global Hospital Acquired Disease Testing Market, By Infection Type, 2022 (US$ Mn)
FIG. 5 Global Hospital Acquired Disease Testing Market, by Application, 2022 (US$ Mn)
FIG. 6 Global Hospital Acquired Disease Testing Market, by Test Type, 2022 (US$ Mn)
FIG. 7 Global Hospital Acquired Disease Testing Market, by Product, 2022 (US$ Mn)
FIG. 8 Global Hospital Acquired Disease Testing Market, by End User, 2022 (US$ Mn)
FIG. 9 Global Hospital Acquired Disease Testing Market, by Geography, 2022 (US$ Mn)
FIG. 10 Attractive Investment Proposition, By Infection Type, 2022
FIG. 11 Attractive Investment Proposition, by Application, 2022
FIG. 12 Attractive Investment Proposition, by Test Type, 2022
FIG. 13 Attractive Investment Proposition, by Product, 2022
FIG. 14 Attractive Investment Proposition, by End User, 2022
FIG. 15 Attractive Investment Proposition, by Geography, 2022
FIG. 16 Global Market Share Analysis of Key Hospital Acquired Disease Testing Market Manufacturers, 2022
FIG. 17 Global Market Positioning of Key Hospital Acquired Disease Testing Market Manufacturers, 2022
FIG. 18 Global Hospital Acquired Disease Testing Market Value Contribution, By Infection Type, 2022 & 2030 (Value %)
FIG. 19 Global Hospital Acquired Disease Testing Market, by Hospital Acquired Pneumonia Hospital Acquired Disease Testing, Value, 2017-2030 (US$ Mn)
FIG. 20 Global Hospital Acquired Disease Testing Market, by Bloodstream Infections Hospital Acquired Disease Testing, Value, 2017-2030 (US$ Mn)
FIG. 21 Global Hospital Acquired Disease Testing Market, by Surgical Site Infections , Value, 2017-2030 (US$ Mn)
FIG. 22 Global Hospital Acquired Disease Testing Market, by Gastrointestinal Infections, Value, 2017-2030 (US$ Mn)
FIG. 23 Global Hospital Acquired Disease Testing Market, by Urinary Tract Infections (UTI), Value, 2017-2030 (US$ Mn)
FIG. 24 Global Hospital Acquired Disease Testing Market, by Others, Value, 2017-2030 (US$ Mn)
FIG. 25 Global Hospital Acquired Disease Testing Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 26 Global Hospital Acquired Disease Testing Market, by Disease Testing, Value, 2017-2030 (US$ Mn)
FIG. 27 Global Hospital Acquired Disease Testing Market, by Drug-Resistance Testing, 2017-2030 (US$ Mn)
FIG. 28 Global Hospital Acquired Disease Testing Market Value Contribution, By Test Type, 2022 & 2030 (Value %)
FIG. 29 Global Hospital Acquired Disease Testing Market, by Molecular Diagnostics, Value, 2017-2030 (US$ Mn)
FIG. 30 Global Hospital Acquired Disease Testing Market, by Immunoassay, 2017-2030 (US$ Mn)
FIG. 31 Global Hospital Acquired Disease Testing Market, by Others, 2017-2030 (US$ Mn)
FIG. 32 Global Hospital Acquired Disease Testing Market Value Contribution, By Product, 2022 & 2030 (Value %)
FIG. 33 Global Hospital Acquired Disease Testing Market, by Instrument, Value, 2017-2030 (US$ Mn)
FIG. 34 Global Hospital Acquired Disease Testing Market, by Reagents and Consumables, 2017-2030 (US$ Mn)
FIG. 35 Global Hospital Acquired Disease Testing Market Value Contribution, By End User, 2022 & 2030 (Value %)
FIG. 36 Global Hospital Acquired Disease Testing Market, by Standalone Laboratories, Value, 2017-2030 (US$ Mn)
FIG. 37 Global Hospital Acquired Disease Testing Market, by Hospitals, 2017-2030 (US$ Mn)
FIG. 38 Global Hospital Acquired Disease Testing Market, by Others, 2017-2030 (US$ Mn)
FIG. 39 North America Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 40 U.S. Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 41 Canada Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 42 Europe Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 43 Germany Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 44 France Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 45 U.K. Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 46 Italy Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 47 Spain Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 48 Rest of Europe Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 49 Asia Pacific Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 50 China Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 51 Japan Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 52 India Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 53 South Korea Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 54 South-East Asia Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 55 Rest of Asia Pacific Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 56 Latin America Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 57 Brazil Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 58 Mexico Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 59 Rest of Latin America Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 60 Middle East & Africa Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 61 GCC Countries Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 62 South Africa Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)
FIG. 63 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, 2017-2030 (US$ Mn)

 

List of Tables
TABLE 1 Market Snapshot: Global Hospital Acquired Disease Testing Market
TABLE 2 Global Hospital Acquired Disease Testing Market: Market Drivers Impact Analysis
TABLE 3 Global Hospital Acquired Disease Testing Market: Market Restraints Impact Analysis
TABLE 4 Global Hospital Acquired Disease Testing Market, by Competitive Benchmarking, 2022
TABLE 5 Global Hospital Acquired Disease Testing Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Hospital Acquired Disease Testing Market, by Key Strategies Analysis, 2022
TABLE 7 Global Hospital Acquired Disease Testing Market, by Hospital Acquired Pneumonia Hospital Acquired Disease Testing, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global Hospital Acquired Disease Testing Market, by Hospital Acquired Pneumonia Hospital Acquired Disease Testing, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global Hospital Acquired Disease Testing Market, by Bloodstream Infections Hospital Acquired Disease Testing, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global Hospital Acquired Disease Testing Market, by Bloodstream Infections Hospital Acquired Disease Testing, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global Hospital Acquired Disease Testing Market, by Surgical Site Infections , By Region, 2017-2022 (US$ Mn)
TABLE 12 Global Hospital Acquired Disease Testing Market, by Surgical Site Infections , By Region, 2023-2030 (US$ Mn)
TABLE 13 Global Hospital Acquired Disease Testing Market, by Gastrointestinal Infections, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global Hospital Acquired Disease Testing Market, by Gastrointestinal Infections, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global Hospital Acquired Disease Testing Market, by Urinary Tract Infections (UTI), By Region, 2017-2022 (US$ Mn)
TABLE 16 Global Hospital Acquired Disease Testing Market, by Urinary Tract Infections (UTI), By Region, 2023-2030 (US$ Mn)
TABLE 17 Global Hospital Acquired Disease Testing Market, by Others, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global Hospital Acquired Disease Testing Market, by Others, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global Hospital Acquired Disease Testing Market, by Disease Testing, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global Hospital Acquired Disease Testing Market, by Disease Testing, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global Hospital Acquired Disease Testing Market, by Drug-Resistance Testing, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global Hospital Acquired Disease Testing Market, by Drug-Resistance Testing, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global Hospital Acquired Disease Testing Market, by Molecular Diagnostics, By Region, 2017-2022 (US$ Mn)
TABLE 24 Global Hospital Acquired Disease Testing Market, by Molecular Diagnostics, By Region, 2023-2030 (US$ Mn)
TABLE 25 Global Hospital Acquired Disease Testing Market, by Immunoassay, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global Hospital Acquired Disease Testing Market, by Immunoassay, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global Hospital Acquired Disease Testing Market, by Others, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global Hospital Acquired Disease Testing Market, by Others, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global Hospital Acquired Disease Testing Market, by Instrument, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global Hospital Acquired Disease Testing Market, by Instrument, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global Hospital Acquired Disease Testing Market, by Reagents and Consumables, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global Hospital Acquired Disease Testing Market, by Reagents and Consumables, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global Hospital Acquired Disease Testing Market, by Standalone Laboratories, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global Hospital Acquired Disease Testing Market, by Standalone Laboratories, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global Hospital Acquired Disease Testing Market, by Hospitals, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global Hospital Acquired Disease Testing Market, by Hospitals, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global Hospital Acquired Disease Testing Market, by Others, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global Hospital Acquired Disease Testing Market, by Others, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 40 Global Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 41 Global Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 42 Global Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 43 Global Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 44 Global Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 45 Global Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 46 Global Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 47 Global Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 48 Global Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 49 Global Hospital Acquired Disease Testing Market, by Region, 2017-2022 (US$ Mn)
TABLE 50 Global Hospital Acquired Disease Testing Market, by Region, 2023-2030 (US$ Mn)
TABLE 51 North America Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 52 North America Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 53 North America Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 54 North America Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 55 North America Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 56 North America Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 57 North America Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 58 North America Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 59 North America Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 60 North America Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 61 North America Hospital Acquired Disease Testing Market, by Country, 2017-2022 (US$ Mn)
TABLE 62 North America Hospital Acquired Disease Testing Market, by Country, 2023-2030 (US$ Mn)
TABLE 63 United States Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 64 United States Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 65 United States Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 66 United States Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 67 United States Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 68 United States Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 69 United States Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 70 United States Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 71 United States Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 72 United States Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 73 Canada Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 74 Canada Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 75 Canada Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 76 Canada Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 77 Canada Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 78 Canada Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 79 Canada Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 80 Canada Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 81 Canada Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 82 Canada Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 83 Mexico Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 84 Mexico Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 85 Mexico Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 86 Mexico Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 87 Mexico Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 88 Mexico Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 89 Mexico Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 90 Mexico Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 91 Mexico Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 92 Mexico Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 93 Europe Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 94 Europe Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 95 Europe Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 96 Europe Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 97 Europe Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 98 Europe Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 99 Europe Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 100 Europe Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 101 Europe Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 102 Europe Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 103 Europe Hospital Acquired Disease Testing Market, by Country, 2017-2022 (US$ Mn)
TABLE 104 Europe Hospital Acquired Disease Testing Market, by Country, 2023-2030 (US$ Mn)
TABLE 105 Germany Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 106 Germany Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 107 Germany Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 108 Germany Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 109 Germany Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 110 Germany Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 111 Germany Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 112 Germany Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 113 Germany Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 114 Germany Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 115 France Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 116 France Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 117 France Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 118 France Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 119 France Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 120 France Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 121 France Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 122 France Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 123 France Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 124 France Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 125 United Kingdom Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 126 United Kingdom Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 127 United Kingdom Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 128 United Kingdom Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 129 United Kingdom Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 130 United Kingdom Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 131 United Kingdom Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 132 United Kingdom Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 133 United Kingdom Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 134 United Kingdom Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 135 Italy Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 136 Italy Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 137 Italy Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 138 Italy Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 139 Italy Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 140 Italy Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 141 Italy Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 142 Italy Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 143 Italy Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 144 Italy Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 145 Spain Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 146 Spain Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 147 Spain Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 148 Spain Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 149 Spain Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 150 Spain Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 151 Spain Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 152 Spain Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 153 Spain Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 154 Spain Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 155 Rest of Europe Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 156 Rest of Europe Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 157 Rest of Europe Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 158 Rest of Europe Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 159 Rest of Europe Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 160 Rest of Europe Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 161 Rest of Europe Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 162 Rest of Europe Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 163 Rest of Europe Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 164 Rest of Europe Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 165 Asia Pacific Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 166 Asia Pacific Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 167 Asia Pacific Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 168 Asia Pacific Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 169 Asia Pacific Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 170 Asia Pacific Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 171 Asia Pacific Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 172 Asia Pacific Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 173 Asia Pacific Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 174 Asia Pacific Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 175 China Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 176 China Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 177 China Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 178 China Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 179 China Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 180 China Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 181 China Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 182 China Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 183 China Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 184 China Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 185 Japan Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 186 Japan Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 187 Japan Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 188 Japan Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 189 Japan Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 190 Japan Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 191 Japan Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 192 Japan Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 193 Japan Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 194 Japan Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 195 India Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 196 India Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 197 India Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 198 India Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 199 India Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 200 India Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 201 India Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 202 India Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 203 India Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 204 India Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 205 South Korea Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 206 South Korea Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 207 South Korea Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 208 South Korea Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 209 South Korea Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 210 South Korea Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 211 South Korea Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 212 South Korea Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 213 South Korea Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 214 South Korea Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 215 South-East Asia Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 216 South-East Asia Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 217 South-East Asia Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 218 South-East Asia Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 219 South-East Asia Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 220 South-East Asia Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 221 South-East Asia Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 222 South-East Asia Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 223 South-East Asia Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 224 South-East Asia Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 225 Rest of Asia Pacific Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 226 Rest of Asia Pacific Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 227 Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 228 Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 229 Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 230 Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 231 Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 232 Rest of Asia Pacific Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 233 Rest of Asia Pacific Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 234 Rest of Asia Pacific Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 235 Latin America Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 236 Latin America Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 237 Latin America Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 238 Latin America Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 239 Latin America Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 240 Latin America Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 241 Latin America Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 242 Latin America Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 243 Latin America Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 244 Latin America Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 245 Brazil Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 246 Brazil Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 247 Brazil Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 248 Brazil Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 249 Brazil Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 250 Brazil Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 251 Brazil Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 252 Brazil Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 253 Brazil Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 254 Brazil Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 255 Argentina Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 256 Argentina Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 257 Argentina Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 258 Argentina Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 259 Argentina Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 260 Argentina Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 261 Argentina Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 262 Argentina Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 263 Argentina Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 264 Argentina Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 265 Rest of Latin America Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 266 Rest of Latin America Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 267 Rest of Latin America Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 268 Rest of Latin America Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 269 Rest of Latin America Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 270 Rest of Latin America Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 271 Rest of Latin America Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 272 Rest of Latin America Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 273 Rest of Latin America Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 274 Rest of Latin America Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 275 Middle East and Africa Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 276 Middle East and Africa Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 277 Middle East and Africa Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 278 Middle East and Africa Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 279 Middle East and Africa Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 280 Middle East and Africa Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 281 Middle East and Africa Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 282 Middle East and Africa Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 283 Middle East and Africa Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 284 Middle East and Africa Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 285 GCC Countries Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 286 GCC Countries Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 287 GCC Countries Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 288 GCC Countries Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 289 GCC Countries Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 290 GCC Countries Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 291 GCC Countries Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 292 GCC Countries Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 293 GCC Countries Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 294 GCC Countries Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 295 South Africa Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 296 South Africa Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 297 South Africa Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 298 South Africa Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 299 South Africa Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 300 South Africa Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 301 South Africa Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 302 South Africa Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 303 South Africa Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 304 South Africa Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)
TABLE 305 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, By Infection Type, 2017-2022 (US$ Mn)
TABLE 306 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, By Infection Type, 2023-2030 (US$ Mn)
TABLE 307 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, by Application, 2017-2022 (US$ Mn)
TABLE 308 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, by Application, 2023-2030 (US$ Mn)
TABLE 309 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, by Test Type, 2017-2022 (US$ Mn)
TABLE 310 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, by Test Type, 2023-2030 (US$ Mn)
TABLE 311 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, by Product, 2017-2022 (US$ Mn)
TABLE 312 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, by Product, 2023-2030 (US$ Mn)
TABLE 313 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, by End User, 2017-2022 (US$ Mn)
TABLE 314 Rest of Middle East and Africa Hospital Acquired Disease Testing Market, by End User, 2023-2030 (US$ Mn)

Frequently Asked Questions

How does COVID-19 Impact the global hospital acquired disease testing market?

COVID-19 has had a major impact on the market due to the outbreak of the COVID-19 pandemic, which increased the demand for hospital acquired disease testing.

Which is the leading region of the hospital market acquired disease testing?

North America accounted for the most heightened global hospital acquired disease testing market share.

What are the key drivers for the growth of the hospital acquired disease testing market?

Increasing cases of hospital acquired infections to drive the drug abuse testing market.

Which is the major hospital acquired disease testing market segment by product?

The reagent and consumables segment had a major global market share in 2022.

Which is the major segment in the hospital acquired disease testing market by the end user?

The hospital segment had a major share in the global market.

Digital PCR Market

Published:
Report ID: 12323

In-Vitro ADME Services Market

Published:
Report ID: 11191

Europe Distributed Solar Power Generation Market

Published:
Report ID: 37132

Biotechnology Contract Manufacturing Market

Published:
Report ID: 36713

Cell Culture Media And Reagents Market

Published:
Report ID: 3489

Viral Antigens Market

Published:
Report ID: 36114

Recombinant Protein Market

Published:
Report ID: 35991

Bacteriophage Market

Published:
Report ID: 2114

India Bone Marrow Transplantation (BMT) Market

Published:
Report ID: 35571

Bioengineered Skin And Skin Substitutes Market

Published:
Report ID: 3472

DNA and RNA Sample Preparation Market

Published:
Report ID: 34911

Laboratory Filtration Market

Published:
Report ID: 7940

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN